Celgene’s acquisition will expand its oncology franchise

Thursday 1 July 2010

Celgene Corp is set to expand its oncology franchise with an agreed cash and stock offer for Abraxis BioScience Inc of California which has a marketed treatment for metastatic breast cancer. The deal will establish Celgene in solid tumours.

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Location

United States